Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients
Clinical trial NCT03281824 · COMPLETED
Trial details
- NCT number
- NCT03281824
- Sponsor
- Alteogen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2020-03-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.